CrossrefInfokarte
Comparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study
Intestinal Research · 2026-09-10
DOI: 10.5217/ir.2026.00152 ↗Abstract
Kein Abstract verfügbar.
EUVIMED